Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSLE

NASDAQHealthcareBiotechnology

最新資料

US$5.68

−US$0.12 · -2.07%

載入中

MSLE公司概覽

公司概況

Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.